VREOF 8-K 2026-08-05

Vireo Growth Inc. (VREOF) 8-K dated 2026-08-05 — accession 0001104659-26-091266.

Vireo Growth Inc. (VREOF) is a drug manufacturers - specialty & generic company listed on OTCQX.

Vireo Growth Inc. filed a 8-K on 2026-08-05. Accession 0001104659-26-091266.

This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VREOF revenue for 2025-12-31 was $268.8M. Net income was -$68.1M. Revenue was up 170.4% from 2024-12-31 to 2025-12-31. VREOF currently screens at market cap $773.5M.

Not investment advice. The VREOF SEC hub lists recent forms. The stock page is the research view.